Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
Actuate Therapeutics Inc.
ETOP IBCSG Partners Foundation
OncoSec Medical Incorporated
Ludwig-Maximilians - University of Munich
Brown University
NYU Langone Health
Celgene
Universitaire Ziekenhuizen KU Leuven
Icahn School of Medicine at Mount Sinai
Celgene
GERCOR - Multidisciplinary Oncology Cooperative Group
Celgene Corporation
Kaiser Permanente
Veeda Oncology